Jian Xu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Top Venues

Advanced materials (Deerfield Beach, Fla.)

Advanced biology

Cancer communications (London, England)

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Xu, Xiang Li, Yue Du
Antibody-Pattern Recognition Receptor Agonist Conjugates: A Promising Therapeutic Strategy for Cancer. Advanced biology 6 (3) (2022)
Mengran Zhang, Hao Cai, Yue Du, Yuexuan Wang, Jianhua Gong, Jian Xu, Xiujun Liu
Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination. Molecular pharmaceutics 18 (3) (2021)
Brendan Hagerty, T Norene O'Sullivan, Xianyu Zhang, N Keith Collins, Wendi Custer Lawrence, Laura L Bassel, Nathan M Pate, Jian Xu, Theresa M Guerin, Serguei Kozlov, Christine Alewine
Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers. Molecular cancer therapeutics 20 (10) (2021)
Yue Du, Jian Xu
Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges. Advanced materials (Deerfield Beach, Fla.) 33 (48) (2021)
Jian Xu, Mayrel Palestino Dominguez, Christine Alewine
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci. Cancer communications (London, England) (2021)
Mingyuan Zou, Yue Du, Ruizhen Liu, Zeliang Zheng, Jian Xu
Nanocarrier-delivered small interfering RNA for chemoresistant ovarian cancer therapy. Wiley interdisciplinary reviews. RNA 12 (5) (2021)